FDG-PET Parameters as Predictors of Pathologic Response and Nodal Clearance in Patients with Stage III Non–small Cell Lung Cancer Receiving Neoadjuvant Chemoradiation and Surgery

Small Cell ◽

Pathologic Response ◽

Stage Iii ◽

FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery

Practical Radiation Oncology ◽

10.1016/j.prro.2017.04.013 ◽

2017 ◽

Vol 7 (6) ◽

pp. e531-e541 ◽

Cited By ~ 3

Author(s):

Andrea L. Arnett ◽

Ann T. Packard ◽

Kristin Mara ◽

Aaron S. Mansfield ◽

Dennis A. Wigle ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Fdg Pet ◽

Small Cell ◽

Pathologic Response ◽

Stage Iii ◽

Does Pathologic Response to Neoadjuvant Chemoradiation to 60 Gy Predict Survival in Locally Advanced Non-Small Cell Lung Cancer?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.1798 ◽

2016 ◽

Vol 96 (2) ◽

pp. E465

Author(s):

S. Appel ◽

J.D. Goldstein ◽

Z. Symon ◽

Y. Lawrence ◽

J. Bar ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Pathologic Response ◽

Patterns of Regional Failure in Stage III Non-small Cell Lung Cancer Managed With Neoadjuvant Chemoradiation Therapy and Resection

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.1546 ◽

2012 ◽

Vol 84 (3) ◽

pp. S580

Author(s):

S. Garg ◽

B.T. Gielda ◽

J. Turian ◽

M. Liptay ◽

W.H. Warren ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chemoradiation Therapy ◽

Stage Iii ◽

Small Cell Lung ◽

Neoadjuvant Chemoradiation Therapy ◽

Regional Failure

5P Comparison of PD-L1 expression before and after neoadjuvant chemoradiation or chemotherapy in stage III non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1016/j.annonc.2021.10.021 ◽

2021 ◽

Vol 32 ◽

pp. S1376

Author(s):

D. König ◽

S. Savic Prince ◽

B. Trachsel ◽

S. Hayoz ◽

M. Pless

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Before And After

Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-006-0197-0 ◽

2006 ◽

Vol 34 (1) ◽

pp. 54-59 ◽

Cited By ~ 21

Author(s):

S. M. Eschmann ◽

G. Friedel ◽

F. Paulsen ◽

M. Reimold ◽

T. Hehr ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Fdg Pet ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

18F Fdg

Neoadjuvant Chemoradiation With Paclitaxel/Carboplatin for Selected Stage III Non–Small-Cell Lung Cancer: Long-Term Results of a Trimodality Phase II Protocol

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.03.077 ◽

2010 ◽

Vol 76 (5) ◽

pp. 1376-1381 ◽

Cited By ~ 10

Author(s):

Thomas Hehr ◽

Godehard Friedel ◽

Volker Steger ◽

Werner Spengler ◽

Susanne M. Eschmann ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Long Term Results ◽

Postoperative survivin expression in stage III non-small cell lung cancer (NSCLC) patients treated with neoadjuvant chemoradiation.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7034 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7034-7034

Author(s):

M. J. Fidler ◽

S. Basu ◽

K. A. Kaiser-Walters ◽

E. Hadziahmetovic ◽

M. Batus ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Survivin Expression ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Nsclc Patients

Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2004.06.102 ◽

2004 ◽

Vol 78 (6) ◽

pp. 1903-1909 ◽

Cited By ~ 116

Author(s):

Robert J. Cerfolio ◽

Ayesha S. Bryant ◽

Thomas S. Winokur ◽

Buddhiwardhan Ohja ◽

Alfred A. Bartolucci

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Neoadjuvant Therapy ◽

Cell Lung Cancer ◽

Fdg Pet ◽

Small Cell ◽

Pathologic Response ◽

Pretreatment FDG-PET Metrics in Stage III Non-Small Cell Lung Cancer: ACRIN 6668/RTOG 0235

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djv004 ◽

2015 ◽

Vol 107 (4) ◽

pp. djv004-djv004 ◽

Cited By ~ 37

Author(s):

N. Ohri ◽

F. Duan ◽

M. Machtay ◽

J. J. Gorelick ◽

B. S. Snyder ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Fdg Pet ◽

Small Cell ◽

Stage Iii ◽

The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-020-04711-3 ◽

2020 ◽

Vol 47 (5) ◽

pp. 1209-1219 ◽

Cited By ~ 4

Author(s):

Xiuli Tao ◽

Ning Li ◽

Ning Wu ◽

Jie He ◽

Jianming Ying ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Fdg Pet ◽

Small Cell ◽

Pathologic Response ◽

Small Cell Lung ◽

Pet Ct ◽

18F Fdg ◽

Fdg Pet Ct